⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 7, 2022Climacteric

Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study

Margherita Angelucci F. Frascani A. Franceschelli A. Lusi Maria Luisa Garo

View at Publisher

Ask AI

Bookmark

Share

Abstract

Vulvovaginal intradermal injection of PN/HA is a safe, effective treatment, is not expensive and is a reproducible procedure in postmenopausal women with VVA.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Angelucci et al. (2022) studied this question.

synapsesocial.com/papers/69d945679873513554835b74 https://doi.org/10.1080/13697137.2022.2052840

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Recent Review of the Genitourinary Syndrome of MenopauseReview · 2015 · 171 citations
2Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE studyCross-Sectional Study · 2018 · 152 citations
3Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopauseSurvey · 2014 · 286 citations
4Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal womenOriginal Research · 2008 · 296 citations
5Genitourinary syndrome of menopause: Common problem, effective treatmentsOriginal Research · 2018 · 41 citations

The role of local vaginal estrogen for treatment of vaginal atrophy2007
Recommendations for the management of postmenopausal vaginal atrophy2010
Management of symptomatic vulvovaginal atrophy2013
Effects of testosterone on exercise capacity in postmenopausal women with stage B heart failureClimacteric · 2026
Reclaiming agency: how women build mood, confidence and social connections during perimenopauseClimacteric · 2026

More from Climacteric

More from Fatebenefratelli Hospital